Efficacy and Safety of Continuous Versus Intermittent Nebulization of Salbutamol in Acute Severe Asthma in Children Under 12 Years of Age

Summary

Asthma affects around 260 million people globally, causing around 0.5 million deaths annually. Pediatric asthma remains a major global public health challenge, significantly affecting the quality of life for many children. Therefore, this study was planned to compare the effects of continuous versus intermittent nebulization of salbutamol in the treatment of acute severe asthma (ASA) in children visiting the emergency department of a tertiary childcare hospital in South Punjab, Pakistan.

Timeline

Start

2024-04-01

Primary completion

2024-09-30

Completion

2024-09-30

Publications

• Zulqarnain A, Fayyaz A, Zafar S, Fatima B. Continuous versus intermittent nebulization of salbutamol in acute Severe asthma in children under 12 years of age. Pak J Med Sci. 2026 Jan;42(1):185-190. doi: 10.12669/pjms.42.1.11935.

Drugs

Indications